Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
M. McClung, M. O'Donoghue, S. Papapoulos, H. Bone +36 more
2019The Lancet Diabetes and Endocrinology148 citations Open access
Semantic Scholar

